JNJ - JOHNSON & JOHNSON
Close
145.76
-20.440 -14.023%
Share volume: 0
Last Updated: Tue 24 Dec 2024 06:00:07 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
19.80%
PREVIOUS CLOSE
CHG
CHG%
$166.20
-20.44
-12.30%
View ratios
| Fiscal Date | 2022-10-02 | 2023-01-01 | 2023-04-02 | 2023-07-02 | 2023-10-01 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-10-27 | 2023-02-16 | 2023-04-28 | 2023-07-31 | 2023-10-27 | 2024-02-16 | 2024-05-01 | 2024-07-25 | |
| Assets | |||||||||
| Total Assets | 175.124 B | 187.378 B | 195.969 B | 191.686 B | 166.061 B | 167.558 B | 171.966 B | 181.088 B | |
| Current Assets | 65.236 B | 55.294 B | 64.388 B | 60.567 B | 53.703 B | 53.495 B | 57.002 B | 57.817 B | |
| Inventories | 11.675 B | 12.483 B | 12.809 B | 12.888 B | 11.198 B | 11.181 B | 11.383 B | 12.169 B | |
| Other Current Assets | 3.592 B | 3.132 B | 2.921 B | 2.397 B | 4.196 B | 4.514 B | 4.455 B | 4.379 B | |
| Short Term Investments | 3.592 B | 3.132 B | 2.921 B | 2.397 B | 4.196 B | 4.514 B | 4.455 B | 4.379 B | |
| Total Receivables | 15.890 B | 16.160 B | 16.350 B | 16.777 B | 14.798 B | 14.873 B | 14.946 B | 15.794 B | |
| Current Cash | 34.079 B | 23.519 B | 24.613 B | 28.505 B | 23.511 B | 22.927 B | 26.218 B | 25.475 B | |
| Total Non-current Assets | 109.888 B | 132.084 B | 131.581 B | 131.119 B | 112.358 B | 114.063 B | 114.964 B | 123.271 B | |
| Property Plant Equipment | 18.152 B | 19.803 B | 20.174 B | 20.576 B | 18.821 B | 19.898 B | 19.632 B | 19.748 B | |
| Other Assets | 8.625 B | 9.026 B | 9.567 B | 10.078 B | 13.133 B | 9.680 B | 14.125 B | 10.544 B | |
| Intangible Assets | 40.336 B | 48.325 B | 47.448 B | 46.246 B | 35.021 B | 34.175 B | 34.286 B | 39.725 B | |
| Goodwill | 33.383 B | 45.231 B | 45.575 B | 45.440 B | 36.124 B | 36.558 B | 36.616 B | 44.250 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 175.124 B | 187.378 B | 195.969 B | 191.686 B | 166.061 B | 167.558 B | 171.966 B | 181.088 B | |
| Total liabilities | 100.525 B | 110.574 B | 125.100 B | 116.537 B | 94.833 B | 98.784 B | 101.946 B | 109.550 B | |
| Total current liabilities | 45.543 B | 55.802 B | 60.373 B | 54.170 B | 44.370 B | 46.282 B | 48.725 B | 53.933 B | |
| Accounts Payable | 10.153 B | 11.703 B | 9.909 B | 10.443 B | 8.355 B | 9.632 B | 8.174 B | 8.848 B | |
| Other liabilities | 22.433 B | 21.510 B | 25.382 B | 23.579 B | 21.789 B | 23.428 B | 24.967 B | 21.346 B | |
| Current long term debt | 4.424 B | 12.771 B | 17.979 B | 11.701 B | 3.870 B | 3.451 B | 8.550 B | 9.855 B | |
| Long term debt | 27.603 B | 26.888 B | 34.928 B | 33.901 B | 26.051 B | 25.881 B | 25.082 B | 31.636 B | |
| Other liabilities | 22.433 B | 21.510 B | 25.382 B | 23.579 B | 21.789 B | 23.428 B | 24.967 B | 21.346 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 1.260 B | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 74.599 B | 76.804 B | 70.869 B | 75.149 B | 71.228 B | 68.774 B | 70.020 B | 71.538 B | |
| Common stock | 2.628 B | 2.614 B | 2.606 B | 2.598 B | 2.523 B | 2.407 B | 2.408 B | 2.407 B | |
| Retained earnings | 127.917 B | 128.345 B | 124.558 B | 129.381 B | 152.536 B | 153.843 B | 153.378 B | 155.360 B |